MEDIFAST (MED)
(Delayed Data from NYSE)
$18.30 USD
-0.30 (-1.61%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $18.31 +0.01 (0.05%) 7:20 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.30 USD
-0.30 (-1.61%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $18.31 +0.01 (0.05%) 7:20 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
6 Must-Buy Quality Stocks Screened on DuPont Analysis
by Sanghamitra Saha
Bet on six top-ranked stocks with higher ROE derived the DuPont way.
The Zacks Analyst Blog Highlights: Reynolds Consumer Products, Ollie's Bargain Outlet, Medifast and Flowers Foods
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Reynolds Consumer Products, Ollie's Bargain Outlet, Medifast and Flowers Foods
What's in the Cards for Medifast (MED) This Earnings Season?
by Zacks Equity Research
Strength in OPTAVIA brand is likely to get reflected in Medifast's (MED) second-quarter 2020 performance. However, rising SG&A expenses is a concern.
Has MEDIFAST INC (MED) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
4 Essential Goods Stocks to Tap the Rise in Consumer Spending
by Ritujay Ghosh
The gradual easing of restrictions followed by the opening of the economy will boost spending which had hit rock bottom over the past few of months.
The Zacks Analyst Blog Highlights: BGS, MNST, MED, NUS and FLO
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BGS, MNST, MED, NUS and FLO
Here's How Beyond Meat (BYND) is Placed Ahead of Q2 Earnings
by Zacks Equity Research
Beyond Meat's (BYND) second-quarter results are likely to reflect strength in the retail business due to higher at-home consumption, while the foodservice business may remain under pressure.
What's in Store for Monster Beverage's (MNST) Q2 Earnings?
by Zacks Equity Research
Monster Beverage's (MNST) energy drink category is likely to have favorably impacted the company's second-quarter earnings results.
Top 5 Consumer Staple Stocks Ahead of Q2 Earnings Results
by Nalak Das
The consumer staples sector has so far reported relatively better results despite the decline of overall sector's earnings year over year.
Medifast (MED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Medifast (MED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here Are the Factors Influencing Clorox's (CLX) Q4 Earnings
by Zacks Equity Research
Clorox's (CLX) Q4 performance is likely to have gained on increased demand for its products due to the coronavirus outbreak and cost-saving plans. However, currency woes and high costs are concerning.
Kellogg (K) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Kellogg (K) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Things to Note Ahead of Procter & Gamble's (PG) Q4 Earnings
by Zacks Equity Research
Strong demand for Procter & Gamble's (PG) products, which are deemed essential, is likely to have aided performance in fiscal fourth quarter.
The Zacks Analyst Blog Highlights: Turning Point Brands, Medifast, Emergent BioSolutions, Thermo Fisher Scientific and Sempra Energy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Turning Point Brands, Medifast, Emergent BioSolutions, Thermo Fisher Scientific and Sempra Energy
Jobless Claims Rise First Time Since March: 5 Defensive Picks
by Sreoshi Bera
The spike in unemployment claims and looming coronavirus fears have made markets volatile, making defensive picks lucrative investment options.
Looking for a Growth Stock? 3 Reasons Why Medifast (MED) is a Solid Choice
by Zacks Equity Research
Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.
Smucker Announces Dividend Hike: What Else Should You Know?
by Zacks Equity Research
Smucker (SJM) rewards shareholders by raising dividend for the 19th consecutive year.
Will Medifast Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor of Medifast
Zacks.com featured highlights include: Medifast, USANA Health Sciences, UFP Industries, EMCOR and AllianceBernstein
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, USANA Health Sciences, UFP Industries, EMCOR and AllianceBernstein
Can Medifast (MED) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Medifast (MED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
At-Home Food Consumption is Likely to Keep Growing: 5 Picks
by Ansuiya Mohta
Mounting fears related to coronavirus have raised vulnerability, making at-home food consumption the new normal.
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
Zacks.com featured highlights include: A10 Networks, Fortinet, Valmont Industries and Medifast
by Zacks Equity Research
Zacks.com featured highlights include: A10 Networks, Fortinet, Valmont Industries and Medifast
4 Best-in-Bracket Liquid Stocks for Alluring Returns
by Zacks Equity Research
Here are four top-ranked liquid gems, including Fortinet (FTNT), that investors can add to portfolio for remarkable returns.
Lamb Weston's Solid Price/Mix Bodes Well, High Costs Hurt
by Zacks Equity Research
Lamb Weston (LW) looks well poised on robust price/mix, focus on LTOs and capacity expansion. However, higher input and manufacturing costs are concerning.